Research Article
Latent Toxoplasmosis among Breast Cancer Patients in Jahrom, South of Iran
Figure 1
(a) The overall seroprevalence rate of T. gondii among breast cancer patients; (b) seroprevalence among menopause and nonmenopause patients (); (c) seroprevalence among patients with and without previous breast cancer history (); (d) seroprevalence among HER2-positive and -negative patients ().
(a) |
(b) |
(c) |
(d) |